Printer-friendly versionNeutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered 2 patient cohort and their implications
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered 2 patient cohort and their implications
The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to correlate with recovery and protection of this disease. However, the characteristics of these antibodies have not been well studied in association with the clinical manifestations in patients
Publication Date:
30/03/2020
1-20
